找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Radiotherapy in Skin Cancer; A Practical Guide on Kurian Jones Joseph,Michael J. Veness,Agata Rembie Book 2023 The Editor(s) (if applicable

[復(fù)制鏈接]
樓主: Concave
21#
發(fā)表于 2025-3-25 06:28:26 | 只看該作者
22#
發(fā)表于 2025-3-25 09:43:00 | 只看該作者
Lipry and primary radical radiotherapy are equal treatment modalities for early-stage carcinomas; adjuvant radiotherapy improves outcomes for those with lip carcinomas with high-risk features..The evidence base lacks prospective data on patient-reported outcome measures and quality-of-life metrics; dat
23#
發(fā)表于 2025-3-25 15:08:48 | 只看該作者
Ear ear is a high-risk region for locoregional recurrence. Treatment planning can be challenging given the irregular surface contours of the ear. Treatment may be delivered with kilovoltage, electrons, photons, and brachytherapy depending on the site of disease presentation.
24#
發(fā)表于 2025-3-25 18:41:12 | 只看該作者
25#
發(fā)表于 2025-3-25 20:40:00 | 只看該作者
Primary Melanoma and Lentigo Maligna after complete excision of a primary melanoma to reduce local recurrence based on certain pathological indications. RT is rarely used as the primary treatment for certain patients with unresectable primary melanoma after multidisciplinary team discussion. For lentigo maligna, RT is an acceptable no
26#
發(fā)表于 2025-3-26 00:08:26 | 只看該作者
Merkel Cell Carcinomaere on the body, and most (50–60%) patients present with a primary lesion with the incidence of subclinical nodal spread high (30–50%). There is an extensive body of evidence supporting the addition of adjuvant radiotherapy in improving locoregional control and survival. Patients are often not suita
27#
發(fā)表于 2025-3-26 07:49:57 | 只看該作者
28#
發(fā)表于 2025-3-26 11:58:38 | 只看該作者
Regional Radiotherapy in Head and Neck Non-melanoma Skin Cancernd neck region. Optimal management of NMSC with metastatic regional disease involves surgery and adjuvant radiotherapy (RT). Elective nodal RT may occasionally be considered in select cases with a high-risk primary character. The addition of chemotherapy to RT in locoregionally advanced cutaneous sq
29#
發(fā)表于 2025-3-26 13:22:43 | 只看該作者
30#
發(fā)表于 2025-3-26 19:30:50 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-14 22:12
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
馆陶县| 普兰县| 新乡市| 庄河市| 苗栗县| 梁平县| 冕宁县| 长顺县| 察隅县| 唐河县| 贵港市| 易门县| 凉山| 特克斯县| 苏尼特右旗| 兴山县| 新河县| 开原市| 抚远县| 泰宁县| 呼和浩特市| 砚山县| 马尔康县| 通榆县| 新民市| 武威市| 江孜县| 黑水县| 平山县| 民乐县| 汾阳市| 共和县| 鸡西市| 融水| 衡阳市| 三亚市| 扎鲁特旗| 仁化县| 日喀则市| 武定县| 旬阳县|